Literature DB >> 12399951

Vasopressin V1b receptor knockout reduces aggressive behavior in male mice.

S R Wersinger1, E I Ginns, A-M O'Carroll, S J Lolait, W S Young.   

Abstract

Increased aggression is commonly associated with many neurological and psychiatric disorders. Current treatments are largely empirical and are often accompanied by severe side effects, underscoring the need for a better understanding of the neural bases of aggression. Vasopressin, acting through its 1a receptor subtype, is known to affect aggressive behaviors. The vasopressin 1b receptor (V1bR) is also expressed in the brain, but has received much less attention due to a lack of specific drugs. Here we report that mice without the V1bR exhibit markedly reduced aggression and modestly impaired social recognition. By contrast, they perform normally in all the other behaviors that we have examined, such as sexual behavior, suggesting that reduced aggression and social memory are not simply the result of a global deficit in sensorimotor function or motivation. Fos-mapping within chemosensory responsive regions suggests that the behavioral deficits in V1bR knockout mice are not due to defects in detection and transmission of chemosensory signals to the brain. We suggest that V1bR antagonists could prove useful for treating aggressive behavior seen, for example, in dementias and traumatic brain injuries.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12399951     DOI: 10.1038/sj.mp.4001195

Source DB:  PubMed          Journal:  Mol Psychiatry        ISSN: 1359-4184            Impact factor:   15.992


  125 in total

1.  Oxytocin, vasopressin and estrogen receptor gene expression in relation to social recognition in female mice.

Authors:  Amy E Clipperton-Allen; Anna W Lee; Anny Reyes; Nino Devidze; Anna Phan; Donald W Pfaff; Elena Choleris
Journal:  Physiol Behav       Date:  2011-11-03

Review 2.  Genetics of vasopressin receptors.

Authors:  Marc Thibonnier
Journal:  Curr Hypertens Rep       Date:  2004-02       Impact factor: 5.369

3.  Neurohypophyseal hormones manipulation modulate social and anxiety-related behavior in zebrafish.

Authors:  Daniela Braida; Andrea Donzelli; Roberta Martucci; Valeria Capurro; Marta Busnelli; Bice Chini; Mariaelvina Sala
Journal:  Psychopharmacology (Berl)       Date:  2011-09-29       Impact factor: 4.530

4.  Modular genetic control of sexually dimorphic behaviors.

Authors:  Xiaohong Xu; Jennifer K Coats; Cindy F Yang; Amy Wang; Osama M Ahmed; Maricruz Alvarado; Tetsuro Izumi; Nirao M Shah
Journal:  Cell       Date:  2012-02-03       Impact factor: 41.582

5.  V1b and CRHR1 receptor heterodimerization mediates synergistic biological actions of vasopressin and CRH.

Authors:  Brigitte Murat; Dominic Devost; Miriam Andrés; Julie Mion; Véra Boulay; Maithé Corbani; Hans H Zingg; Gilles Guillon
Journal:  Mol Endocrinol       Date:  2012-02-02

Review 6.  The Corticohippocampal Circuit, Synaptic Plasticity, and Memory.

Authors:  Jayeeta Basu; Steven A Siegelbaum
Journal:  Cold Spring Harb Perspect Biol       Date:  2015-11-02       Impact factor: 10.005

Review 7.  Vasopressin and alcohol: a multifaceted relationship.

Authors:  Kathryn M Harper; Darin J Knapp; Hugh E Criswell; George R Breese
Journal:  Psychopharmacology (Berl)       Date:  2018-11-03       Impact factor: 4.530

Review 8.  Oxytocin, vasopressin and pair bonding: implications for autism.

Authors:  Elizabeth A D Hammock; Larry J Young
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2006-12-29       Impact factor: 6.237

9.  Selectivity of d[Cha4]AVP and SSR149415 at human vasopressin and oxytocin receptors: evidence that SSR149415 is a mixed vasopressin V1b/oxytocin receptor antagonist.

Authors:  Cristiana Griffante; Andrew Green; Ornella Curcuruto; Carl P Haslam; Bryony A Dickinson; Roberto Arban
Journal:  Br J Pharmacol       Date:  2005-11       Impact factor: 8.739

10.  Individual differences in estrogen receptor alpha in select brain nuclei are associated with individual differences in aggression.

Authors:  Brian C Trainor; Kelly M Greiwe; Randy J Nelson
Journal:  Horm Behav       Date:  2006-06-06       Impact factor: 3.587

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.